Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay

Cancer Genetics and Cytogenetics

Volumn 121, Issue 1, 2000, Pages 38-43

  Takahashi, Yasuo ^a   Nagata, Toshihito ^a   Asai, Satoshi ^a   Shintaku, Kaori ^a   Eguchi, Teruo ^a   Ishii, Yukimoto ^a   Fujii, Masashi ^a   Ishikawa, Koichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CHROMOSOME 17P; CHROMOSOME ABERRATION; COLON CARCINOGENESIS; DIGESTIVE SYSTEM CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS;

CENTROMERE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; COLONIC NEOPLASMS; FLUORESCENT DYES; GENE DOSAGE; GENES, P53; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POINT MUTATION; STOMACH NEOPLASMS;

EID: 0033848702     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00231-4     Document Type: Article

References (23)

1. Sandberg A.A. The Chromosomes in Human Cancer and Leukemia. 2nd Edition:1990;Elsevier Science Publishing Co, New York.
2. Mitelman F. Catalogue of Chromosome Aberrations in Cancer. 4th Edition:1994;Wiley-Liss Publishing Co, New York.
3. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene. clues to cancer etiology and molecular pathogenesis Cancer Res. 54:1994;4855-4878.
4. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P., Glover T., Collins F.S., Weston A., Modali R., Harris C.C., Vogelstein B. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:1989;705-708.
5. Baker S.J., Fearon E.R., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., van Tuinen P., Ledbetter D.H., Barker D.F., Nakamura Y., White R., Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:1989;217-221.
6. Tamura G., Kihana T., Nomura K., Terada M., Sugimura T., Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res. 51:1991;3056-3058.
7. Takahashi Y., Shintaku K., Ishii Y., Asai S., Ishikawa K., Fujii M. Analysis of myc and chromosome 8 copy number changes in gastrointestinal cancers by dual-color fluorescence in situ hybridization. Cancer Genet Cytogenet. 107:1998;61-64.
8. Chen Z., Morgan R., Berger C.S., Sandberg A.A. Application of fluorescence in situ hybridization in hematological disorders. Cancer Genet Cytogenet. 63:1992;62-69.
9. Pinkel D., Landegent J., Collins C., Fuscoe J., Segraves R., Lucas J., Gray J. Fluorescence in situ hybridization with human chromosome-specific libraries. detection of trisomy 21 and translocations of chromosome 4 Proc Natl Acad Sci USA. 85:1988;9138-9142.
10. Ahrendt S.A., Halachmi S., Chor J.T., Wu L., Halachmi N., Yang S.C., Wehage S., Jen J., Sidransky D. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci USA. 96:1999;7382-7387.
11. Hacia J.G., Brody L.C., Chee M.S., Fodor S.P., Collins F.S. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet. 14:1996;441-447.
12. Cronin M.T., Fucini R.V., Kim S.M., Masino R.S., Wespi R.M., Miyada C.G. Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays. Hum Mutat. 7:1996;244-255.
13. Miller C.W., Aslo A., Tsay C., Slamon D., Ishizaki K., Toguchida J., Yamamuro T., Lampkin B., Koeffler H.P. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res. 50:1990;7950-7954.
14. Cho Y., Gorina S., Jeffrey P.D., Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex. understanding tumorigenic mutations Science. 265:1994;346-355.
15. Kastrinakis W.V., Ramchurren N., Rieger K.M., Hess D.T., Loda M., Steele G., Summerhayes I.C. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogne. 11:1995;647-652.
16. Yaseen N.Y., Watmore A.E., Potter A.M., Potter C.W., Jacob G., Rees R.C. Chromosome studies in eleven colorectal tumors. Cancer Genet Cytogenet. 44:1990;83-97.
17. Bomme L., Bardi G., Pandis N., Fenger C., Kronborg O., Heim S. Cytogenetic analysis of colorectal adenomas. karyotypic comparisons of synchronous tumors Cancer Genet Cytogenet. 106:1998;66-71.
18. Milner J., Medcalf E.A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell. 65:1991;765-774.
19. Chene P. In vitro analysis of the dominant negative effect of p53 mutants. J Mol Biol. 281:1998;205-209.
20. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA. 89:1992;7491-7495.
21. Duesberg P., Rausch C., Rasnick D., Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci USA. 95:1998;13692-13697.
22. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instability in colorectal cancers. Nature. 386:1997;623-627.
23. Remvikos Y., Tominaga O., Hammel P., Laurent P.P., Salmon R.J., Dutrillaux B., Thomas G. Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer. 66:1992;758-764.